Your browser doesn't support javascript.
loading
Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity.
Dimas, Antigone S; Lagou, Vasiliki; Barker, Adam; Knowles, Joshua W; Mägi, Reedik; Hivert, Marie-France; Benazzo, Andrea; Rybin, Denis; Jackson, Anne U; Stringham, Heather M; Song, Ci; Fischer-Rosinsky, Antje; Boesgaard, Trine Welløv; Grarup, Niels; Abbasi, Fahim A; Assimes, Themistocles L; Hao, Ke; Yang, Xia; Lecoeur, Cécile; Barroso, Inês; Bonnycastle, Lori L; Böttcher, Yvonne; Bumpstead, Suzannah; Chines, Peter S; Erdos, Michael R; Graessler, Jurgen; Kovacs, Peter; Morken, Mario A; Narisu, Narisu; Payne, Felicity; Stancakova, Alena; Swift, Amy J; Tönjes, Anke; Bornstein, Stefan R; Cauchi, Stéphane; Froguel, Philippe; Meyre, David; Schwarz, Peter E H; Häring, Hans-Ulrich; Smith, Ulf; Boehnke, Michael; Bergman, Richard N; Collins, Francis S; Mohlke, Karen L; Tuomilehto, Jaakko; Quertemous, Thomas; Lind, Lars; Hansen, Torben; Pedersen, Oluf; Walker, Mark.
Afiliação
  • Dimas AS; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Alexander Fleming, Biomedical Sciences Research Center, Vari, Athens, Greece.
  • Lagou V; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.
  • Barker A; Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
  • Knowles JW; Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA.
  • Mägi R; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, U.K.Oxford Centre for Diabetes, Endocrinology & Metabolism, University of Oxford, Oxford, U.K.Estonian Genome Center, University of Tartu, Tartu, Estonia.
  • Hivert MF; Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, CanadaGeneral Medicine Division, Massachusetts General Hospital, Boston, MA.
  • Benazzo A; Department of Biology and Evolution, University of Ferrara, Ferrara, Italy.
  • Rybin D; Boston University Data Coordinating Center, Boston, MA.
  • Jackson AU; Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI.
  • Stringham HM; Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI.
  • Song C; Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, SwedenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Fischer-Rosinsky A; Charité-Universitätsmedizin Berlin, Department of Endocrinology and Metabolism, Berlin, Germany.
  • Boesgaard TW; Steno Diabetes Center, Gentofte, Denmark.
  • Grarup N; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Abbasi FA; Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA.
  • Assimes TL; Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA.
  • Hao K; Department of Genetics and Genomic Sciences, Institute of Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, NY.
  • Yang X; Department of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, CA.
  • Lecoeur C; CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, France.
  • Barroso I; Wellcome Trust Sanger Institute, Hinxton, U.K.University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, U.K.
  • Bonnycastle LL; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Böttcher Y; IFB AdiposityDiseases, Leipzig University Medical Center, Leipzig, Germany.
  • Bumpstead S; Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Chines PS; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Erdos MR; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Graessler J; Department of Medicine III, Division of Prevention and Care of Diabetes, University of Dresden, Dresden, Germany.
  • Kovacs P; Interdisciplinary Center for Clinical Research Leipzig, Leipzig, Germany.
  • Morken MA; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Narisu N; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Payne F; Wellcome Trust Sanger Institute, Hinxton, U.K.
  • Stancakova A; Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Swift AJ; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Tönjes A; IFB AdiposityDiseases, Leipzig University Medical Center, Leipzig, GermanyDepartment of Medicine, University of Leipzig, Leipzig, Germany.
  • Bornstein SR; Department of Medicine III, Division of Prevention and Care of Diabetes, University of Dresden, Dresden, Germany.
  • Cauchi S; CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, France.
  • Froguel P; CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, FranceDepartment of Genomics of Common Disease, Imperial College London, London, U.K.
  • Meyre D; CNRS UMR8199-Institute of Biology, Pasteur Institute, Lille 2-Droit et Santé University, Lille, FranceDepartment of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, Ontario, Canada.
  • Schwarz PE; Department of Medicine III, Division of Prevention and Care of Diabetes, University of Dresden, Dresden, Germany.
  • Häring HU; Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany.
  • Smith U; Lundberg Laboratory for Diabetes Research, Center of Excellence for Metabolic and Cardiovascular Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Boehnke M; Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI.
  • Bergman RN; Department of Physiology & Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA.
  • Collins FS; Genome Technology Branch, National Human Genome Research Institute, Bethesda, MD.
  • Mohlke KL; Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Tuomilehto J; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, FinlandCentre for Vascular Prevention, Danube University Krems, Krems, AustriaKing Abdulaziz University, Jeddah, Saudi Arabia.
  • Quertemous T; Department of Medicine and Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA.
  • Lind L; Department of Medical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsala, Sweden.
  • Hansen T; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkFaculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Pedersen O; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkHagedorn Research Institute, Copenhagen, DenmarkInstitute of Biomedical Science, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Den
  • Walker M; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, U.K.
Diabetes ; 63(6): 2158-71, 2014 Jun.
Article em En | MEDLINE | ID: mdl-24296717
ABSTRACT
Patients with established type 2 diabetes display both ß-cell dysfunction and insulin resistance. To define fundamental processes leading to the diabetic state, we examined the relationship between type 2 diabetes risk variants at 37 established susceptibility loci, and indices of proinsulin processing, insulin secretion, and insulin sensitivity. We included data from up to 58,614 nondiabetic subjects with basal measures and 17,327 with dynamic measures. We used additive genetic models with adjustment for sex, age, and BMI, followed by fixed-effects, inverse-variance meta-analyses. Cluster analyses grouped risk loci into five major categories based on their relationship to these continuous glycemic phenotypes. The first cluster (PPARG, KLF14, IRS1, GCKR) was characterized by primary effects on insulin sensitivity. The second cluster (MTNR1B, GCK) featured risk alleles associated with reduced insulin secretion and fasting hyperglycemia. ARAP1 constituted a third cluster characterized by defects in insulin processing. A fourth cluster (TCF7L2, SLC30A8, HHEX/IDE, CDKAL1, CDKN2A/2B) was defined by loci influencing insulin processing and secretion without a detectable change in fasting glucose levels. The final group contained 20 risk loci with no clear-cut associations to continuous glycemic traits. By assembling extensive data on continuous glycemic traits, we have exposed the diverse mechanisms whereby type 2 diabetes risk variants impact disease predisposition.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Predisposição Genética para Doença / Locos de Características Quantitativas / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Insulina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Predisposição Genética para Doença / Locos de Características Quantitativas / Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Insulina Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans / Male Idioma: En Ano de publicação: 2014 Tipo de documento: Article